Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Miscellaneous and site unspecified neoplasms malignant and unspecified
ADR ID BADD_A02790
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10027655
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01120Ibuprofen--
BADD_D01127Idarubicin--
BADD_D01130Idelalisib0.000504%
BADD_D01133Ifosfamide0.000772%
BADD_D01136Imatinib0.043238%
BADD_D01142Imiquimod--
BADD_D01149Indapamide0.000377%
BADD_D01156Indomethacin--
BADD_D01157Infliximab--
BADD_D01158Ingenol mebutate--
BADD_D01162Insulin detemir--
BADD_D01163Insulin glargine--
BADD_D01167Interferon alfa-2b--
BADD_D01179Ioflupane i-123--
BADD_D01195Irinotecan0.004432%
BADD_D01196Irinotecan hydrochloride--
BADD_D01197Iron0.000453%
BADD_D01223Ixazomib0.002037%
BADD_D01230Ketoconazole0.000099%
BADD_D01244Lanreotide acetate--
BADD_D01245Lansoprazole--
BADD_D01248Lapatinib0.004309%
BADD_D01250Lasofoxifene--
BADD_D01251Latanoprost--
BADD_D01252Leflunomide0.002357%
BADD_D01253Lenalidomide0.012490%
BADD_D01254Lenvatinib0.025542%
BADD_D01257Letrozole0.033059%
BADD_D01258Leucovorin0.015365%
BADD_D01260Leuprolide acetate0.008604%
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 18 Pages